Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Aims: To test in an outpatient setting the safety and efficacy of continuous subcutaneous insulin infusion ( CSII ) driven by a modular model predictive control ( MMPC ) algorithm informed by continuous glucose monitoring ( CGM ) measurement. Methods: 13 patients affected by type 1 diabetes participated to a non‐randomized outpatient 42‐h experiment that included two evening meals and overnight periods (in short, dinner & night periods). CSII was patient‐driven during dinner & night period 1 and MMPC‐driven during dinner&night period 2. The study was conducted in hotels, where patients could move around freely. A CGM system ( G4 Platinum; D excom I nc., S an D iego, CA , USA ) and insulin pump ( AccuChek C ombo; R oche D iagnostics, M annheim, G ermany) were connected wirelessly to a smartphone‐based platform (DiAs, Diabetes Assistant; U niversity of V irginia, C harlottesville, VA , USA ) during both periods. Results: A significantly lower percentage of time spent with glucose levels <3.9 mmol/l was achieved in period 2 compared with period 1: 1.96 ± 4.56% vs 12.76 ± 15.84% (mean ± standard deviation, p < 0.01), together with a greater percentage of time spent in the 3.9–10 mmol/l target range: 83.56 ± 14.02% vs 62.43 ± 29.03% (p = 0.04). In addition, restricting the analysis to the overnight phases, a lower percentage of time spent with glucose levels <3.9 mmol/l (1.92 ± 4.89% vs 12.7 ± 19.75%; p = 0.03) was combined with a greater percentage of time spent in 3.9–10 mmol/l target range in period 2 compared with period 1 (92.16 ± 8.03% vs 63.97 ± 2.73%; p = 0.01). Average glucose levels were similar during both periods. Conclusions: The results suggest that MMPC managed by a wearable system is safe and effective during evening meal and overnight. Its sustained use during this period is currently being tested in an ongoing randomized 2‐month study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Threshold-based insulin-pump interruption for reduction of hypoglycemia
Bergenstal, R. M., Klonoff, D. C., Garg, S. K., Bode, B. W., Meredith, M., Slover, R. H., Ahmann, A. J., Welsh, J. B., Lee, S. W., & Kaufman, F. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303576 · Cited by 652
Artificial Pancreas: Past, Present, Future
Cobelli, C., Renard, E., & Kovatchev, B. (2011) · Diabetes · doi:10.2337/db11-0654 · Cited by 600
Self-citationFully Integrated Artificial Pancreas in Type 1 Diabetes
Breton, M., Farret, A., Bruttomesso, D., Anderson, S., Magni, L., Patek, S., Dalla Man, C., Place, J., Demartini, S., Del Favero, S., et al. (2012) · Diabetes · doi:10.2337/db11-1445 · Cited by 315
Self-citationKovatchev, B., Cobelli, C., Renard, E., Anderson, S., Breton, M., Patek, S., Clarke, W., Bruttomesso, D., Maran, A., Costa, S., et al. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400611 · Cited by 200
Self-citationFirst use of model predictive control in outpatient wearable artificial pancreas
Del Favero, S., Bruttomesso, D., Di Palma, F., Lanzola, G., Visentin, R., Filippi, A., Scotton, R., Toffanin, C., Messori, M., Scarpellini, S., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1631 · Cited by 103
Self-citation
Cited by
Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes
Rodbard, D. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0035 · Cited by 458
Coming of age: the artificial pancreas for type 1 diabetes
Thabit, H., & Hovorka, R. (2016) · Diabetologia · doi:10.1007/s00125-016-4022-4 · Cited by 223
Multinational Home Use of Closed-Loop Control Is Safe and Effective
Anderson, S. M., Raghinaru, D., Pinsker, J. E., Boscari, F., Renard, E., Buckingham, B. A., Nimri, R., Doyle, F. J., Brown, S. A., Keith-Hynes, P., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2468 · Cited by 120
Self-citationGingras, V., Taleb, N., Roy‐Fleming, A., Legault, L., & Rabasa‐Lhoret, R. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13052 · Cited by 113
Renard, E., Farret, A., Kropff, J., Bruttomesso, D., Messori, M., Place, J., Visentin, R., Calore, R., Toffanin, C., Di Palma, F., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0008 · Cited by 104
Self-citation
Metadata
- Authors
- Del Favero, S., Place, J., Kropff, J., Messori, M., Keith‐Hynes, P., Visentin, R., Monaro, M., Galasso, S., Boscari, F., Toffanin, C., Di Palma, F., Lanzola, G., Scarpellini, S., Farret, A., Kovatchev, B., Avogaro, A., Bruttomesso, D., Magni, L., DeVries, J. H., Cobelli, C., Renard, E., & on behalf of the AP@home Consortium
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2015-02-16
- Volume
- 17
- Issue
- 5
- Pages
- 468-476
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2109916332
- Cited by
- 90
- References
- 5
- FWCI
- 13.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes. https://app.cochat.ai/papers/10.1111/dom.12440
- The paper
- Del Favero, S., Place, J., Kropff, J., Messori, M., Keith‐Hynes, P., Visentin, R., Monaro, M., Galasso, S., Boscari, F., Toffanin, C., Di Palma, F., Lanzola, G., Scarpellini, S., Farret, A., Kovatchev, B., Avogaro, A., Bruttomesso, D., Magni, L., DeVries, J. H., . . . on behalf of the AP@home Consortium. (2015). Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.12440
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.